ST. JUDE MEDICAL 2016 CMS HOSPITAL OUTPATIENT AND AMBULATORY SURGICAL CENTER REIMBURSEMENT PROSPECTUS

whitePaper | November 24, 2022

The life sciences industry has been exploring ways to accelerate the study start up process for well over a decade. The industry has long understood the value behind faster clinical trials: the sooner clinical trial results can be delivered to agencies

whitePaper | July 26, 2022

Healthcare leaders have long recognized the importance of real-time decision making. Take, for instance, sepsis one of the leading causes of U.S. hospital deaths that costs the industry an estimated $62B a year,1 not to mention the preventable morbidity

whitePaper | June 3, 2022

With increased scrutiny from regulatory agencies, advocacy groups and the public for clinical trial transparency, sponsors are feeling the pressure to ramp up efforts to make their studies more accessible.

whitePaper | October 12, 2022

The configurability options of a deep digital health white label span from how you accept patients, to how you coordinate care, to how you treat specific medical conditions. This is difficult to achieve with a static solution with fixed capabilities.

whitePaper | January 13, 2023

The COVID-19 pandemic and response measures presented many hardships to people living in Sub-Saharan Africa.

whitePaper | September 21, 2022

Prior to 2020, the answer was likely not very much. Although decentralized trials (DCT) existed prior to the pandemic, COVID-19 undoubtedly had a large impact on the rapid adoption of DCT technologies.